Anne-France Moreau counsels clients on corporate and general commercial law, with a particular focus on pharmaceutical, medical device and health care industries. Anne-France has experience on a number of merger, acquisition and private equity transactions, including divestitures, financing rounds and joint ventures for French and non-French corporations. She assists French and non-French groups in the preparation and negotiation of collaborations, licenses and distribution agreements. She also advises companies in the health care sector in connection with pharmaceutical and regulatory issues.
Previously, Anne-France worked as an associate in the corporate and securities and life sciences group of another international law firm. She also worked in a legal department of a French major leading pharmaceutical company, where she gained experience in pharmaceutical operations.
Assisted Innate Pharma in its research collaboration and licensing agreement with Sanofi to apply Innate Pharma’s new proprietary technology to the development of innovative bispecific antibody formats engaging natural killer (NK) cells to kill tumor cells through the activating receptor NKp46
Advised Innate Pharma, as part of the McDermott team, in its exclusive licensing agreement with OREGA Biotech that grants Innate Pharma full, worldwide rights to OREGA Biotech’s program of first-in-class anti-CD39 checkpoint inhibitors
Advised Pierre Fabre on the Framework of Collaboration Agreement with Array BioPharma to globally develop and commercialize Array’s two late-stage oncology molecules: binimetinib and encorafenib
Represented Arterial Remodeling Technologies (ART), a French medtech developing an active bioabsorbable stent for the treatment of coronary disease, on its structured sale to the Japanese group Terumo Corporation
Advised the founders of Blink Biomedical SAS in the creation of a new biotechnology company formed by Valneva and the shareholders of Blink Therapeutics dedicated to the discovery of monoclonal antibodies, and its first financing round
University of Paris I Panthéon-Sorbonne, Licence in Private Law, 2006
University of Paris I Panthéon-Sorbonne, Master’s 1, Business Law, 2007
University of Paris V Descartes, Master’s 2, Business and European Law, 2008
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.